ReviewInnovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted Therapies
Under an Elsevier user license
open archive
Cited by (0)
Supported by grants from the Research Concerted Action program (IDEA project), from the CEE [FP7 network: ADAMANT-Antibody derivatives as molecular agents for neoplastic targeting (HEALTH-F2-2007-201342)], from the National Fund for Scientific Research (NFSR, Belgium), from TELEVIE, from the Centre Anti-Cancéreux of the University of Liège, and is made in collaboration with the GIGA-Proteomics Platform at the University of Liège, Belgium.
CME Disclosure: None of the authors disclosed any relevant financial relationships.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.